期刊文献+

真性红细胞增多症患者骨髓CD_(34)阳性细胞凋亡及增殖特征研究 被引量:6

Apoptosis and proliferation of CD_ (34)positive bone marrow cells in patients with polycythemia vera
原文传递
导出
摘要 目的 了解真性红细胞增多症 (PV)患者骨髓CD34 阳性细胞的凋亡、增殖情况。方法 应用双色流式细胞仪检测 2 0例PV患者及 10例原发性血小板增多症 (ET)患者和 12名正常人骨髓CD34 阳性细胞AnnexinⅤ以及细胞增殖相关抗原Ki6 7的表达情况并分析其与PV临床表现的相关性。结果 PVCD34 阳性细胞AnnexinⅤ表达率为 (15 .96± 1.4 5 ) % ,ET为 (15 .5 3± 1.76 ) % ,明显低于正常对照组的 (2 3.6 1± 3.89) % (P <0 .0 5 ) ;CD34 阳性细胞Ki6 7表达率PV为 (4 8.79± 11.6 8) % ,ET为 (4 9.6 0±9.98) % ,明显高于正常对照组的 (33.87± 6 .82 ) % (P <0 .0 1) ;凋亡增殖比PV为 0 .33± 0 .10 ,ET为 0 .32± 0 .0 2 ,明显低于正常对照组的 0 .72± 0 .11(P <0 .0 1) ;CD34 阳性细胞凋亡与血红蛋白、白细胞计数、内源性红系集落呈负相关 (分别r=- 0 .4 81,P =0 .0 37;r=- 0 .5 38,P =0 .0 2 6 ;r=- 0 .6 32 ,P =0 5 0 )。凋亡增殖比与血红蛋白、白细胞计数呈负相关 (分别r=- 0 .5 37,P =0 .0 18;r=- 0 .6 6 7,P =0 0 0 3)。结论 PV患者骨髓CD34 阳性细胞有低凋亡及高增殖特点 ,低凋亡与疾病严重度相关。 Objective To study the apoptosis and proliferation of CD 34 positive(CD 34+) bone marrow cells(BMC) in patients with polycythemia vera(PV). Methods The expression of Annexin V and Ki67 of the CD 34+ BMC in 20 PV patients and control cases [10 essential thrombocythemia(ET), 12 normal persons] were assessed by bicolor flow cytometry (FCM), and the correlation between apoptosis and clinical situation was analysed in PV patients. Results The Annexin V expressions of CD 34+BMC were (15.96±1.45)% in PV patients and (15.53±1.76)% in ET patients which were lower than that in normal subjects [(23.61±3.89)%,(P<0.05)]. The Ki67 expression of CD 34+ BMC was(48.79±11.68)% in PV patients and (49.60±9.98)% in ET patients, which were significantly higher than that in normal controls (33.87±6.82)%. The ratio of apoptosis/proliferation in PV patients was 0.33±0.10 and in ET patients 0.32±0.02 which were significantly lower than that in normal controls 0.72±0.11 (P<0.01). The apoptosis of CD 34+ BMC was negatively correlated with the hemoglobin(Hb) levels (r=-0.481,P=0.037), white blood cells (WBC) (r=-0.538,P=0.026) and the numbers of endogenous erythroid colony(EEC)(r=-0.632,P=0.50), and the ratio of apoptosis/proliferation was negatively correlated with the Hb(r=-0.537,P=0.018)and WBC(r=-0.667,P=0.003) in PV patients. Conclusion There were lower apoptosis and higher proliferation in CD 34+ BMC of PV patients. Lower apoptosis was correlated with the severity of the disease.
机构地区 中国医学科学院
出处 《中华血液学杂志》 CAS CSCD 北大核心 2004年第4期195-197,共3页 Chinese Journal of Hematology
关键词 真性红细胞增多症 骨髓CD34阳性细胞 细胞凋亡 细胞增殖 双色流式细胞仪 骨髓造血于细胞 Polycythemia, vera Hematopoietic stem cell, bone marrow Apoptosis Proliferation
  • 相关文献

参考文献7

  • 1Silva M, Grillot D, Nunez G, et al. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2.Blood, 1996, 88: 1576-1582.
  • 2Kelley LL, Koury M J, Bondurant MC, et al. Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities:a mechanism for controlled rates of erythrocyte production. Blood, 1993,82:2340-2352.
  • 3Prchal JF, Axelrad AA. Letter: bone-marrow responses in polycythemia vera. N EnglJ Med,1974,290:1382.
  • 4Koopman G, Reutelingsperger CP, Kuijten GA,et al. Annexin Ⅴ for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood,1994,84:1415-1420.
  • 5Gerdes J, Schwab U, Lemke H, et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer,1983,31:13-20.
  • 6白洁,邵宗鸿,井丽萍,刘鸿,施均,赵明峰,付蓉,何广胜,孙娟,贾海蓉,钱林生,杨天楹,杨崇礼.185例真性红细胞增多症的临床分析[J].中华血液学杂志,2002,23(11):578-580. 被引量:28
  • 7白洁,邵宗鸿.真性红细胞增多症造血干及祖细胞生物学特征的研究进展[J].中华内科杂志,2002,41(2):140-142. 被引量:14

二级参考文献21

  • 1Kralovics R,Indrak K,Stopka T, et al. Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias. Blood, 1997,90:2057-2061.
  • 2Chiba S, Takahashi T, Takeshita K, et al. Selective expression of mRNA coding for the truncated form of erythropoietin receptor in hematopoietic cells and its decrease in patients with polycythemia vera. Blood, 1997, 90:97-104.
  • 3Le Couedic JP, Mitjavila MT, Villeval JL, et al. Missense mutation of the erythropoietin receptor is a rare event in human erythroid malignancies. Blood, 1996, 87:1502-1511.
  • 4Yan XQ, Lacey D, Fletcher F,et al. Chronic expossure to retroviral vector encoded MGDF(mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood, 1995, 86:4025-4033.
  • 5Kieran MW, Perkins AC, Orkin SH, et al. Thrombopoietin rescues in vitro erythroid colony formation from mouse embryos lacking the erythropoietin receptor. Proc Natl Acad Sci USA, 1996, 93:9126-9131.
  • 6Ratajczak MZ, Ratajczak J, Marlicz W, et al. Recombinant human thrombopoietin(TPO) stimulates erythropoiesis by inhibiting erythroid progenitor cell apoptosis. Br J Haematol, 1997,98:8-18.
  • 7Moliterno AR, Hankins, WD, Spivak JL. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med, 1998,338:572-580.
  • 8Moliterno AR, Spivak JL. Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera. Blood,1999,94:2555-2561.
  • 9Le Blanc K, Andersson P, Samuelsson J. Marked heterogeneity in protein levels and functional integrity of the thrombopoietin receptor c-mpl in polycythaemia vera. Br J Haematol, 2000,108:80-85.
  • 10Temerinac S, Klippel S,Struck E, et al. Cloning of PRV-1,a novel member of the uPAR receptor superfamily ,which is overexpressed in polycythemia rubra vera. Blood, 2000,95:2569-2576.

共引文献36

同被引文献39

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部